AQST - Aquestive Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AQST is currently covered by 6 analysts with an average price target of $7.92. This is a potential upside of $4.86 (158.82%) from yesterday's end of day stock price of $3.06.

Aquestive Therapeutics's activity chart (see below) currently has 37 price targets and 58 ratings on display. The stock rating distribution of AQST is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.6% with an average time for these price targets to be met of 81.63 days.

Highest price target for AQST is $9.5, Lowest price target is $7, average price target is $7.92.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-May-2024. First documented stock forecast 20-Aug-2018.

Currently out of the existing stock ratings of AQST, 26 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$5.94 (194.12%)

9

17 days ago

8/18 (44.44%)

$5.71 (173.56%)

290

Buy

7

$3.94 (128.76%)

10

1 months 28 days ago

0/8 (0%)

$2.74 (64.32%)

Buy

8

$4.94 (161.44%)

2 months 19 days ago

1/5 (20%)

$2.32 (40.85%)

52

Buy

9

$5.94 (194.12%)

4

2 months 19 days ago

5/6 (83.33%)

$3.32 (58.45%)

259

Buy

8

$4.94 (161.44%)

8

8 months 5 days ago

0/6 (0%)

$6.37 (390.80%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AQST (Aquestive Therapeutics) average time for price targets to be met?

On average it took 81.63 days on average for the stock forecasts to be realized with a an average price target met ratio 21.6

Which analyst has the current highest performing score on AQST (Aquestive Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on AQST (Aquestive Therapeutics) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on AQST (Aquestive Therapeutics)?

Raghuram Selvaraju has 3 price targets and 16 ratings on AQST

Which analyst is the currently most bullish on AQST (Aquestive Therapeutics)?

Francois Brisebois with highest potential upside - $6.3

Which analyst is the currently most reserved on AQST (Aquestive Therapeutics)?

Gary Nachman with lowest potential downside - $3.94

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?